Document is current
Any future updates will be listed below
-
Authors
Buchman, Anna https://orcid.org/0000-0002-8775-6147
Shriner, Isaiah https://orcid.org/0000-0002-5897-8250
Yang, Ting https://orcid.org/0000-0001-7201-4231
Liu, Junru
Antoshechkin, Igor https://orcid.org/0000-0002-9934-3040
Marshall, John M. https://orcid.org/0000-0003-0603-7341
Perry, Michael W. https://orcid.org/0000-0002-5977-8031
Akbari, Omar S. https://orcid.org/0000-0002-6853-9884
-
Funding
Funding for this research was provided by:
United States Department of Defense | Defense Advanced Research Projects Agency (HR0011-17-2-0047)
- License Information
-
More Information
Article History
Received: 22 October 2020
Accepted: 23 April 2021
First Online: 2 June 2021
Competing interests
: O.S.A. and A.B. have a patent pending on this technology. Patent applicant—University of California, UCSD. Name of inventor(s)—A.B. and O.S.A. Application number—Invention 2020-184. Status of application—Pending. Specific aspect of manuscript covered in patent application—Using multiplexed dCas9/Cas9/gRNA combinations to generate reproductive isolation that can be used for population control. O.S.A. is co-founder and serves on the scientific advisory board of Agragene. All other authors declare no significant competing financial, professional, or personal interests that might have influenced the performance or presentation of the work described.
